Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00474604 · ClinicalTrials.gov registry record · NA
Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants
A NA study, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
NCT00474604 is a NA study that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 209 participants.
The verdict
NCT00474604, a NA study, has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as MRI, may help diagnose breast cancer. It may also help doctors predict a patient's response to treatment. PURPOSE: This clinical trial is studying breast MRI in women with known or suspected breast cancer and in healthy participants.
Interventions
- PROCEDURE diffusion-weighted magnetic resonance imaging
- PROCEDURE dynamic contrast-enhanced magnetic resonance imaging
- PROCEDURE magnetic resonance spectroscopic imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2006-03 |
| Est. Completion | 2023-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00474604
The ClinicalTrials.gov registry entry for NCT00474604 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which diffusion-weighted magnetic resonance imaging is the first listed.
NCT00474604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00474604 about?
NCT00474604 is a clinical study titled "Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants". RATIONALE: Diagnostic procedures, such as MRI, may help diagnose breast cancer. It may also help doctors predict a patient's response to treatment. PURPOSE: This clinical trial is studying breast MRI in women with known or suspected breast cancer and in healthy participants.
What is the current status of trial NCT00474604?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2006-03. Estimated completion is 2023-04-25.
What interventions are being tested in trial NCT00474604?
The interventions under investigation include: diffusion-weighted magnetic resonance imaging (PROCEDURE), dynamic contrast-enhanced magnetic resonance imaging (PROCEDURE), magnetic resonance spectroscopic imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00474604?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.